Monday, January 20, 2014
TalkMed (IPO)
Catalist IPO - TalkMed : offering 105.143m new shares at $0.20 each by way of placement.
Its' principal activity is the provision of specialist doctors and medical staff to Parkway Cancer Centre, which is a division of Parkway Hospitals Singapore for the provision of specialist oncology services.
The sponsor is Hong Leong Finance while the placement agent is UOBKH.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment